A detailed history of Nelson, Van Denburg & Campbell Wealth Management Group, LLC transactions in Repligen Corp stock. As of the latest transaction made, Nelson, Van Denburg & Campbell Wealth Management Group, LLC holds 826 shares of RGEN stock, worth $130,623. This represents 0.01% of its overall portfolio holdings.

Number of Shares
826
Previous 2,638 68.69%
Holding current value
$130,623
Previous $332,000 63.25%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$119.79 - $167.35 $217,059 - $303,238
-1,812 Reduced 68.69%
826 $122,000
Q2 2024

Aug 13, 2024

SELL
$120.0 - $182.95 $6,120 - $9,330
-51 Reduced 1.9%
2,638 $332,000
Q1 2024

Apr 30, 2024

BUY
$170.78 - $208.42 $96,661 - $117,965
566 Added 26.66%
2,689 $494,000
Q4 2023

Jan 30, 2024

BUY
$114.17 - $185.35 $43,841 - $71,174
384 Added 22.08%
2,123 $381,000
Q3 2023

Oct 17, 2023

SELL
$138.78 - $176.51 $26,923 - $34,242
-194 Reduced 10.04%
1,739 $276,000
Q2 2023

Jul 19, 2023

SELL
$138.42 - $180.31 $26,022 - $33,898
-188 Reduced 8.86%
1,933 $273,000
Q1 2023

May 10, 2023

BUY
$154.26 - $198.1 $59,081 - $75,872
383 Added 22.04%
2,121 $357,000
Q4 2022

Feb 14, 2023

BUY
$162.42 - $220.56 $48,076 - $65,285
296 Added 20.53%
1,738 $294,000
Q3 2022

Oct 26, 2022

SELL
$160.42 - $256.21 $92,562 - $147,833
-577 Reduced 28.58%
1,442 $269,000
Q2 2022

Aug 10, 2022

BUY
$140.68 - $188.02 $61,336 - $81,976
436 Added 27.54%
2,019 $327,000
Q1 2022

May 13, 2022

BUY
$161.19 - $257.96 $255,163 - $408,350
1,583 New
1,583 $297,000
Q3 2020

Oct 20, 2020

SELL
$122.51 - $158.27 $173,964 - $224,743
-1,420 Closed
0 $0
Q2 2020

Jul 02, 2020

SELL
$94.33 - $140.48 $51,881 - $77,264
-550 Reduced 27.92%
1,420 $175,000
Q1 2020

Apr 01, 2020

BUY
$84.96 - $109.14 $57,772 - $74,215
680 Added 52.71%
1,970 $190,000
Q4 2019

Feb 11, 2020

BUY
$73.84 - $93.08 $95,253 - $120,073
1,290 New
1,290 $119,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.78B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Nelson, Van Denburg & Campbell Wealth Management Group, LLC Portfolio

Follow Nelson, Van Denburg & Campbell Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.